Arcutis Biotherapeutics I... (ARQT)
Company Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis.
The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata.
The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019.
Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
| Country | United States |
| IPO Date | Jan 31, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 342 |
| CEO | Todd Franklin Watanabe M.A. |
Contact Details
Address: 3027 Townsgate Road Westlake Village, California United States | |
| Website | https://www.arcutis.com |
Stock Details
| Ticker Symbol | ARQT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001787306 |
| CUSIP Number | 03969K108 |
| ISIN Number | US03969K1088 |
| Employer ID | 81-2974255 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Todd Franklin Watanabe M.A. | President, Chief Executive Officer & Director |
| Aleen Hosdaghian | Vice President of Marketing |
| Amanda Sheldon | Head of Corporate Communications |
| Bethany Dudek Ph.D. | Chief Technical Officer |
| Dr. Bhaskar Chaudhuri Ph.D. | Co-Founder & Independent Director |
| Kent Taylor | Senior Vice President of Sales |
| Latha Vairavan | Vice President of Finance & Corporate Controller |
| Todd Tucker | Senior Vice President & Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 29, 2025 | ARS | Filing |
| Apr 29, 2025 | DEFA14A | Filing |
| Apr 29, 2025 | DEF 14A | Filing |
| Apr 10, 2025 | 8-K | Current Report |
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 4 | Filing |
| Mar 26, 2025 | 4 | Filing |
| Mar 20, 2025 | 4 | Filing |
| Mar 17, 2025 | 4 | Filing |
| Mar 04, 2025 | 4 | Filing |